New analogs of vitamin D3

This publication has 24 references indexed in Scilit:

• Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism
  Kidney International, 1997
• Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.
  Journal of Clinical Investigation, 1996
• A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia
  American Journal of Kidney Diseases, 1995
• Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
  Kidney International, 1992
• Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
  New England Journal of Medicine, 1989
• Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.
  Journal of Clinical Investigation, 1989
• Synthetic analogues of vitamin D₃ with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia
  FEBS Letters, 1987
• Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
  New England Journal of Medicine, 1986
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984
• The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis
  Kidney International, 1973